Longeveron Inc.

NASDAQ (USD): Longeveron Inc. (LGVN)

Last Price

2.18

Today's Change

+0.115 (5.55%)

Day's Change

2.09 - 2.21

Trading Volume

193,058

Overview

Market Cap

31 Million

Shares Outstanding

14 Million

Avg Volume

1,130,296

Avg Price (50 Days)

2.08

Avg Price (200 Days)

3.20

PE Ratio

-0.25

EPS

-8.86

Earnings Announcement

08-Nov-2024

Previous Close

2.07

Open

2.10

Day's Range

2.09 - 2.216

Year Range

0.771 - 23.9

Trading Volume

193,263

Price Change Highlight

1 Day Change

5.56%

5 Day Change

-1.13%

1 Month Change

12.05%

3 Month Change

-28.12%

6 Month Change

30.84%

Ytd Change

-83.45%

1 Year Change

-88.79%

3 Year Change

-93.79%

5 Year Change

-97.05%

10 Year Change

-97.05%

Max Change

-97.05%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment